Cystic fibrosis group partners with Moderna founder to find better, potentially curative treatments
Bio Pharma Dive
NOVEMBER 3, 2021
With an initial investment of $20 million, the collaboration will use technologies from various Flagship-backed companies to discover and develop new therapies for the disease.
Let's personalize your content